NHS chief hails SMA drug deal and was that a swipe at Vertex

NHS chief hails SMA drug deal - and was that a swipe at Vertex?

Children in England with the rare muscle wasting disease spinal muscular atrophy (SMA) will get access to Biogen’s super-expensive new drug Spinraza after the manufacturer struck a deal with NHS officials. NHS England chief executive Simon Stevens...

Original Article: NHS chief hails SMA drug deal - and was that a swipe at Vertex?

More From BioPortfolio on "NHS chief hails SMA drug deal - and was that a swipe at Vertex?"